Literature DB >> 2023106

Sensitivity analysis for physiologically based pharmacokinetic models.

D M Hetrick1, A M Jarabek, C C Travis.   

Abstract

The present study evaluates the sensitivity of pharmacokinetic model output to variability in the biochemical and metabolic input parameters. Pharmacokinetic models of three chemicals are chosen for analysis: styrene, methylchloroform, and methylene chloride. Results show that model sensitivities are time-, dose-, and species-dependent and that the most sensitive parameters are the maximum Michaelis-Menten metabolism rate Vmax and the blood/air and fat/air partition coefficients. For humans, the muscle/air partition coefficient is also important. Model output is insensitive to the Michaelis-Menten parameter Km (except for low doses) and to other tissue/air partition coefficients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023106     DOI: 10.1007/bf01062190

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  9 in total

1.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

Authors:  J C Ramsey; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

Review 2.  Physiologically based pharmacokinetic modeling: principles and applications.

Authors:  L E Gerlowski; R K Jain
Journal:  J Pharm Sci       Date:  1983-10       Impact factor: 3.534

3.  [14C]Methyl chloroform (1,1,1-trichloroethane): pharmacokinetics in rats and mice following inhalation exposure.

Authors:  A M Schumann; T R Fox; P G Watanabe
Journal:  Toxicol Appl Pharmacol       Date:  1982-03-15       Impact factor: 4.219

4.  Pharmacokinetics of tetrachloroethylene.

Authors:  R C Ward; C C Travis; D M Hetrick; M E Andersen; M L Gargas
Journal:  Toxicol Appl Pharmacol       Date:  1988-03-30       Impact factor: 4.219

5.  A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat.

Authors:  R J Lutz; R L Dedrick; H B Matthews; T E Eling; M W Anderson
Journal:  Drug Metab Dispos       Date:  1977 Jul-Aug       Impact factor: 3.922

6.  Interspecies extrapolations in risk analysis.

Authors:  C C Travis
Journal:  Toxicology       Date:  1987-12-01       Impact factor: 4.221

7.  Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations.

Authors:  R H Reitz; J N McDougal; M W Himmelstein; R J Nolan; A M Schumann
Journal:  Toxicol Appl Pharmacol       Date:  1988-09-15       Impact factor: 4.219

8.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors:  M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1987-02       Impact factor: 4.219

9.  Quantitative analysis of styrene monomer in polystyrene and foods including some preliminary studies of the uptake and pharmacodynamics of the monomer in rats.

Authors:  J R Withey
Journal:  Environ Health Perspect       Date:  1976-10       Impact factor: 9.031

  9 in total
  7 in total

1.  Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Partial derivative-based sensitivity analysis of models describing target-mediated drug disposition.

Authors:  Anson K Abraham; Wojciech Krzyzanski; Donald E Mager
Journal:  AAPS J       Date:  2007-06-08       Impact factor: 4.009

Review 4.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

5.  Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: a sensitivity analysis.

Authors:  I A Nestorov; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

6.  Use of a local sensitivity analysis to inform study design based on a mechanistic toxicokinetic model for γ-hydroxybutyric acid.

Authors:  Melanie A Felmlee; Wojciech Krzyzanski; Bridget L Morse; Marilyn E Morris
Journal:  AAPS J       Date:  2011-03-09       Impact factor: 4.009

Review 7.  Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

Authors:  D Krewski; J R Withey; L F Ku; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.